Table 3.
Organism | Intravenous antibiotic | Oral antibiotic |
---|---|---|
Empiric antibiotic regimen In case of beta lactam allergies: |
Amoxicillin/clavulanic acid 1200 mg QID Ceftriaxone 2 g qd + metronidazole 500 mg TID Clindamycin 600 mg TID + ciprofloxacin 400 mg TID |
Amoxicillin/clavulanic acid 625 mg TID Clindamycin 600 mg TID AND Ciprofloxacin 750 mg BID |
Staphylococcus aureus (MSSA) and methicillin-sensitive coagulase-negative staphylococci | Flucloxacillin 6 g/24 h |
Clindamycin 600 mg TID Trimethoprim/sulfamethoxazole (co-trimoxazole) 960 mg BID |
Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci |
Vancomycin (follow local antibiotic guideline for dosage) Teicoplanin (follow local antibiotic guideline for dosage) |
Clindamycin 600 mg TID Trimethoprim/sulfamethoxazole (Co-trimoxazole) 960 mg BID Linezolid 600 mg BID Moxifloxacin 400 qd |
Beta haemolytic streptococci | Penicillin 12 mil U/24 h |
Clindamycin 600 mg TID Doxycycline 200 mg BID |
Enterococci |
Amoxicillin 6 g/24 h Vancomycin (follow local antibiotic guideline for dosage) |
Amoxicillin 1000 mg TID Linezolid 600 mg BID |
Enterobacteriaceae |
Amoxicillin 6 g/24 h Ceftriaxone 2 g qd Ciprofloxacin 400 mg TID |
Ciprofloxacin 750 mg BID Trimethoprim/sulfamethoxazole (co-trimoxazole) 960 mg BID |
Non-fermenting gram-negative rods, e.g. Pseudomonas, Enterobacter |
Ceftazidime 3 g/24 h Ciprofloxacin 400 mg TID |
Ciprofloxacin 750 mg BID |
Anaerobes (gram-negative, e.g. Bacteroides) |
Metronidazole 500 mg TID Clindamycin 600 mg TID |
Metronidazole 500 mg TID Clindamycin 600 mg TID |
Anaerobes (gram-positive, e.g. Cutibacterium acnes, Finegoldia) |
Penicillin 12 mil U/24 h Doxycycline 200 mg BID |
Amoxicillin 1000 mg TID Doxycycline 200 mg BID |
The dosages and intervals are not adjusted to renal function. MSSA methicillin-sensitive S. aureus, MRSA methicillin-resistant S. aureus, BID two times per day, TID three times per day, qd daily, QID four times per day